Group 1 - On January 29, 2023, Maipu Medical's stock fell by 3.42%, with a trading volume of 90.3 million yuan [1] - The financing data for Maipu Medical on the same day showed a financing purchase amount of 5.86 million yuan and a financing repayment of 11.41 million yuan, resulting in a net financing outflow of 5.55 million yuan [1] - As of January 29, 2023, the total balance of margin trading for Maipu Medical was 106 million yuan, which accounted for 2.34% of its circulating market value, indicating a high level compared to the past year [1] Group 2 - As of September 30, 2023, Maipu Medical had 6,043 shareholders, a decrease of 2.36% from the previous period, while the average circulating shares per person increased by 2.52% to 9,272 shares [2] - For the period from January to September 2023, Maipu Medical achieved an operating income of 249 million yuan, representing a year-on-year growth of 30.53%, and a net profit attributable to shareholders of 75.85 million yuan, up 43.65% year-on-year [2] Group 3 - Since its A-share listing, Maipu Medical has distributed a total of 85.80 million yuan in dividends, with 79.20 million yuan distributed over the past three years [3] - As of September 30, 2023, the Southern Medical Health Flexible Allocation Mixed A Fund (000452) has exited the top ten circulating shareholders of Maipu Medical [3]
迈普医学1月29日获融资买入586.47万元，融资余额1.06亿元